Δ1-9, alanine 10, asparagine 134, recombinant human interleukin-11
△1-9,丙氨酸10,天冬酰胺134重组人白介素11
Report date: 2022/01/14 13:23:58
Base Information
Drug NameΔ1-9, alanine 10, asparagine 134, recombinant human interleukin-11
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesFuzhou Quanye Economic Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A